Tigam, Narcita M.
HRN: 04-68-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/10/2022
06/14/2022
IV
4.5 G
Q6
HAP On Top Of CAP
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes